Auris formulations for treating otic diseases and conditions
US10272034B2 · kind B2 · utility
7Cited by
59References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2015 |
| Grant date | Apr 30, 2019 |
| Priority date | — |
| Expiry date | Jun 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.